# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Maxim Group analyst Allen Klee maintains Research Solutions (NASDAQ:RSSS) with a Buy and raises the price target from $5 to $6.
Research Solutions (NASDAQ:RSSS) reported quarterly sales of $12.115 million which beat the analyst consensus estimate of $11.9...
Lake Street initiates coverage on Research Solutions (NASDAQ:RSSS) with a Buy rating and announces Price Target of $5.
Powerful AI, combined with comprehensive data, simplifies the discovery and synthesis of clinical trial information to accelera...
Research Solutions (NASDAQ:RSSS) reported quarterly sales of $10.31 million which beat the analyst consensus estimate of $9.79 ...
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share ...
Research Solutions (NASDAQ:RSSS) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of ...